Virchows Archiv

SJR Rank #3,535H-index: 119SJR: 1.221Best quartile: Q1APC: US$4,790
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Medicine (miscellaneous)Q1
  • Pathology and Forensic MedicineQ1
  • Cell BiologyQ2
  • Molecular BiologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Biomedical and Chemical ResearchSarcoma Diagnosis and TreatmentMedical History and ResearchMedical and Health Sciences ResearchCancer and Skin LesionsNeuroendocrine Tumor Research AdvancesLymphoma Diagnosis and TreatmentSalivary Gland Tumors Diagnosis and TreatmentTumors and Oncological CasesSoft tissue tumor case studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

202220250150300450600

Detailed Information

ISSN

0945-6317, 1432-2307

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.70

References per Document

31.47

Coverage

1947-1948, 1950, 1952-1954, 1956, 1958, 1994-2026

Scope

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.

Metrics from SCImago Journal Rank 2025. View on SCImago